Clinical Evidence: What Weight Loss Trials Actually Show
Wegovy vs Mounjaro UK: Understanding Weight Loss Trial Results
The clinical evidence for Wegovy or Mounjaro UK weight loss comes from separate, rigorously conducted trials with different patient populations and study designs. Wegovy's STEP programme evaluated semaglutide in over 4,500 participants, whilst Mounjaro's SURMOUNT trials assessed tirzepatide in similar numbers. In clinical trials, patients taking Wegovy alongside diet and exercise achieved an average weight reduction of approximately 15% at 68 weeks in the landmark STEP 1 study (Wilding et al., NEJM, 2021). These results represent averages across diverse patient groups, with individual responses varying significantly.
Mounjaro's mechanism differs fundamentally from Wegovy, targeting both GIP and GLP-1 receptors as a dual agonist, compared to Wegovy's GLP-1-only approach. Both prescription-only medicines require clinical assessment and ongoing medical supervision. The choice between Wegovy or Mounjaro UK often depends on individual medical history, tolerance profiles, and prescriber recommendation rather than trial percentages alone.
Wegovy or Mounjaro UK Pricing: Complete Cost Breakdown
EverydayMeds offers transparent pricing for both Wegovy or Mounjaro UK treatments, with Wegovy starting at £79.99 for the 0.25mg starter dose. Our pricing structure includes single pens, convenient bundles, and maintenance supplies across all dose strengths. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 to reach these final prices. The Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, providing your first two months of treatment in one convenient order.
Higher maintenance doses reflect the medication's manufacturing complexity, with the 2.4mg maintenance dose priced at £209.99 per pen. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring treatment continuity. Both Wegovy or Mounjaro UK require gradual dose escalation, making our step-up bundles particularly valuable for treatment planning. All orders include next-day cold-chain delivery and comprehensive prescriber support from our GPhC-registered pharmacy (#9012878).
STEP Trial Evidence for Wegovy or Mounjaro UK Decisions
The STEP clinical programme provides robust evidence for Wegovy's effectiveness when combined with lifestyle interventions. STEP 1 demonstrated that patients taking Wegovy alongside diet and exercise achieved significantly greater weight reduction compared to placebo groups. STEP 5 extended this evidence, showing sustained weight management at two years with continued treatment.
The SELECT cardiovascular outcomes trial revealed an additional 20% reduction in major cardiovascular events among patients using Wegovy. This evidence supports weight management as part of broader health improvement strategies. Individual results may vary significantly from clinical trial averages, emphasising the importance of realistic expectations and ongoing medical supervision.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones produced in your intestine. This mechanism reduces appetite by acting on brain centres that control hunger and satiety. The medication may help you feel fuller after smaller meals and can reduce food cravings between eating occasions. Wegovy works most effectively alongside a reduced-calorie diet and increased physical activity, as demonstrated in clinical trials. The once-weekly injection provides consistent medication levels, supporting sustained appetite management. Understanding this mechanism helps explain why gradual dose escalation is necessary and why lifestyle changes remain essential for optimal results.
Wegovy or Mounjaro UK: Complete Ordering Process
Accessing Wegovy or Mounjaro UK through EverydayMeds begins with our 3-minute online clinical assessment covering medical history and current medications. Our qualified prescribers review applications within three working days (24 hours with express service), ensuring safe prescribing practices. Once approved, orders are dispatched via next-day delivery using specialised cold-chain packaging to maintain medication integrity. Each order includes comprehensive patient information leaflets and injection technique guidance. Our ongoing support ensures you understand proper storage, administration, and what to expect during dose escalation phases.
Storage Advantages: Wegovy or Mounjaro UK Practical Differences
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature for up to 6 weeks once removed from refrigeration versus Mounjaro's 21-day limit. This advantage proves particularly valuable for travel or temporary storage disruptions. Before first use, store Wegovy in your refrigerator at 2-8°C, protecting from light and freezing. The FlexTouch pen design provides precise dosing with clear visual confirmation of injection completion. Proper storage maintains medication potency throughout your treatment journey, whether following the standard dose escalation or maintaining your target dose.
Real-World Wegovy or Mounjaro UK Weight Loss Expectations
Clinical trial results provide valuable guidance but individual responses to Wegovy or Mounjaro UK vary significantly based on starting weight, medical history, and lifestyle factors. The STEP trials showed that whilst average weight loss approached 15%, some participants achieved greater reductions whilst others responded more modestly. Factors influencing response include adherence to dietary modifications, exercise consistency, and genetic variations in medication metabolism.
Both treatments require long-term commitment, as the STEP 1 extension study demonstrated weight regain when treatment discontinuation occurred. Successful weight management typically involves viewing these medications as tools supporting broader lifestyle changes rather than standalone solutions. Setting realistic expectations based on clinical evidence rather than extreme outcomes helps maintain motivation throughout your treatment journey.
Expert Support: Choosing Between Wegovy or Mounjaro UK Options
Our prescribing team at EverydayMeds provides individualised guidance for selecting between Wegovy or Mounjaro UK based on your specific medical profile. Factors influencing choice include existing medical conditions, current medications, previous weight management attempts, and personal treatment preferences. Both medications are available through our platform, ensuring access regardless of prescriber recommendation. Professional guidance helps optimise treatment selection and supports successful long-term weight management outcomes. Start your assessment today using code FIRST40 for new customers or DOSE25 for returning patients to access these proven treatments.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
